On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% |
|
0.00% | -83.33% |
05-01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82K | |
+2.87% | 94.22B | |
-4.08% | 37.76B | |
-13.54% | 32.5B | |
+73.38% | 27.75B | |
-11.66% | 16.13B | |
-1.56% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer